Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ALKEM LABORATORIES vs NATCO PHARMA - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    ALKEM LABORATORIES NATCO PHARMA ALKEM LABORATORIES/
NATCO PHARMA
 
P/E (TTM) x 37.5 13.3 281.3% View Chart
P/BV x 6.5 3.5 186.8% View Chart
Dividend Yield % 1.0 0.6 175.1%  

Financials

 ALKEM LABORATORIES   NATCO PHARMA
EQUITY SHARE DATA
    ALKEM LABORATORIES
Mar-23
NATCO PHARMA
Mar-23
ALKEM LABORATORIES/
NATCO PHARMA
5-Yr Chart
Click to enlarge
High Rs3,625847 428.2%   
Low Rs2,835502 564.7%   
Sales per share (Unadj.) Rs970.1148.4 653.9%  
Earnings per share (Unadj.) Rs84.239.2 214.8%  
Cash flow per share (Unadj.) Rs110.248.2 228.7%  
Dividends per share (Unadj.) Rs50.005.50 909.1%  
Avg Dividend yield %1.50.8 189.8%  
Book value per share (Unadj.) Rs756.4267.1 283.2%  
Shares outstanding (eoy) m119.57182.47 65.5%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x3.34.5 73.3%   
Avg P/E ratio x38.417.2 223.0%  
P/CF ratio (eoy) x29.314.0 209.5%  
Price / Book Value ratio x4.32.5 169.1%  
Dividend payout %59.414.0 423.2%   
Avg Mkt Cap Rs m386,207123,049 313.9%   
No. of employees `000NANA-   
Total wages/salary Rs m21,3144,867 437.9%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m115,99327,071 428.5%  
Other income Rs m2,1611,285 168.2%   
Total revenues Rs m118,15328,356 416.7%   
Gross profit Rs m15,0659,117 165.2%  
Depreciation Rs m3,1041,638 189.5%   
Interest Rs m1,074145 740.4%   
Profit before tax Rs m13,0488,619 151.4%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m2,9801,466 203.2%   
Profit after tax Rs m10,0687,153 140.8%  
Gross profit margin %13.033.7 38.6%  
Effective tax rate %22.817.0 134.3%   
Net profit margin %8.726.4 32.8%  
BALANCE SHEET DATA
Current assets Rs m86,06430,003 286.9%   
Current liabilities Rs m37,0716,831 542.7%   
Net working cap to sales %42.285.6 49.3%  
Current ratio x2.34.4 52.9%  
Inventory Days Days3363 51.3%  
Debtors Days Days67115 58.1%  
Net fixed assets Rs m37,24526,571 140.2%   
Share capital Rs m239365 65.5%   
"Free" reserves Rs m90,20848,373 186.5%   
Net worth Rs m90,44748,738 185.6%   
Long term debt Rs m00-   
Total assets Rs m124,54156,574 220.1%  
Interest coverage x13.260.4 21.8%   
Debt to equity ratio x00-  
Sales to assets ratio x0.90.5 194.6%   
Return on assets %8.912.9 69.4%  
Return on equity %11.114.7 75.8%  
Return on capital %15.618.0 86.8%  
Exports to sales %14.60-   
Imports to sales %010.2 0.0%   
Exports (fob) Rs m16,916NA-   
Imports (cif) Rs mNA2,772 0.0%   
Fx inflow Rs m16,91617,256 98.0%   
Fx outflow Rs m4,1902,772 151.1%   
Net fx Rs m12,72714,484 87.9%   
CASH FLOW
From Operations Rs m16,8258,491 198.2%  
From Investments Rs m1,128-4,771 -23.7%  
From Financial Activity Rs m-17,608-3,630 485.1%  
Net Cashflow Rs m416208 200.1%  

Share Holding

Indian Promoters % 56.7 49.7 114.1%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 24.4 25.0 97.7%  
FIIs % 8.5 13.7 61.9%  
ADR/GDR % 0.0 0.0 -  
Free float % 43.3 50.3 86.0%  
Shareholders   65,184 207,571 31.4%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare ALKEM LABORATORIES With:   SUN PHARMA    DIVIS LABORATORIES    CIPLA    DR. REDDYS LAB    ZYDUS LIFESCIENCES    


More on ALKEM LABORATORIES vs Natco Pharma

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

ALKEM LABORATORIES vs Natco Pharma Share Price Performance

Period ALKEM LABORATORIES Natco Pharma S&P BSE HEALTHCARE
1-Day -1.18% -2.11% 1.18%
1-Month -0.99% -3.19% -0.75%
1-Year 52.26% 72.80% 61.82%
3-Year CAGR 21.70% 4.96% 18.16%
5-Year CAGR 22.99% 10.96% 19.79%

* Compound Annual Growth Rate

Here are more details on the ALKEM LABORATORIES share price and the Natco Pharma share price.

Moving on to shareholding structures...

The promoters of ALKEM LABORATORIES hold a 56.7% stake in the company. In case of Natco Pharma the stake stands at 49.7%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of ALKEM LABORATORIES and the shareholding pattern of Natco Pharma.

Finally, a word on dividends...

In the most recent financial year, ALKEM LABORATORIES paid a dividend of Rs 50.0 per share. This amounted to a Dividend Payout ratio of 59.4%.

Natco Pharma paid Rs 5.5, and its dividend payout ratio stood at 14.0%.

You may visit here to review the dividend history of ALKEM LABORATORIES, and the dividend history of Natco Pharma.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising(Closing)

After opening the day on positive note, Indian share markets gained the momentum as the session progressed and ended on firm footing.